Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Update

Fresenius SE & Co. (OTCMKTS:FSNUY) was the recipient of a large growth in short interest during the month of August. As of August 14th, there was short interest totaling 1,029,832 shares, a growth of 796.7% from the July 30th total of 114,842 shares. Based on an average daily trading volume, of 420,053 shares, the short-interest ratio is presently 2.5 days. Approximately 0.0% of the company’s stock are sold short.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a research note on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Fresenius SE & Co. in a report on Thursday, August 6th. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Fresenius SE & Co. presently has an average rating of “Buy”.

Fresenius SE & Co. Stock Down 0.4%

Shares of OTCMKTS FSNUY traded down $0.05 during trading hours on Thursday, hitting $13.43. The company had a trading volume of 12,770 shares, compared to its average volume of 154,357. Fresenius SE & Co. has a 1-year low of $10.33 and a 1-year high of $33.93. The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 0.41. The firm’s 50 day moving average is $12.58 and its 200-day moving average is $12.69. The stock has a market capitalization of $30.26 billion, a P/E ratio of 17.00 and a beta of 0.61.

Fresenius SE & Co. (OTCMKTS:FSNUY) last issued its earnings results on Wednesday, August 5th. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). Fresenius SE & Co. had a return on equity of 10.33% and a net margin of 6.67%.The firm had revenue of $6.91 billion for the quarter, compared to analyst estimates of $6.65 billion. On average, analysts expect that Fresenius SE & Co. will post 1.08 earnings per share for the current fiscal year.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.